Caxton Associates (New York)’s Livongo Health, Inc. Common Stock LVGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-2,971
Closed -$416K 374
2020
Q3
$416K Buy
+2,971
New +$362K 0.04% 135

Caxton Associates (New York)'s LVGO Position: Q4 2020 in Review

Caxton Associates (New York) sold out of Livongo Health, Inc. Common Stock (LVGO) in Q4 2020, closing a stake of 2,971 shares — an estimated $416K sold.

Caxton Associates (New York) first reported a position in LVGO in Q3 2020 and held it in 1 quarter. The position peaked at $416K in Q3 2020. 0 funds tracked by Wall St. Rank hold LVGO as of Q4 2020.

  • Caxton Associates (New York) reported no remaining Livongo Health, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Caxton Associates (New York) sold 2,971 Livongo Health, Inc. Common Stock shares in Q4 2020, an estimated $416K.
  • Caxton Associates (New York) first reported a position in Livongo Health, Inc. Common Stock in Q3 2020 and held it in 1 quarter.
  • Caxton Associates (New York)'s Livongo Health, Inc. Common Stock position peaked at $416K in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Livongo Health, Inc. Common Stock as of Q4 2020.

Based on Caxton Associates (New York)'s 13F filing for Q4 2020, filed 16 Feb 2021.